-
Taxonomy & unit
-
ratio: %
-
Description
-
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
-
Summary
-
Carisma Therapeutics Inc. quarterly Debt-to-equity history and growth rate from Q2 2020 to Q4 2023.
- Carisma Therapeutics Inc. Debt-to-equity for the quarter ending December 31, 2023 was 115 %, a 62.9% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)